Replies to post #172100 on Cytodyn Inc (CYDY)

[misiu143]

All depend on the contract , partnership will be sharing income from the molecule for particular indication , or entire company.
Probably BP will be paying for all the studies related to this indication , and bringing drug to the market .

My friends and I think that here it will be just for some indications , only because CYDY cancel distribution for covid in USA , but they didn't cancel Vyera for HIV,
So it might be for covid and post viral syndrome , maybe some other diseases also....

NASH is VERY big and phase 2 will be finished at the end of this year , so we don't think it will be included here..
This will be a separate partnership or BO , in our opinion..if results of phase 2 will be positive.

But all this is our speculation base on what is happening with other small biotech over many years ..
And here we all will be very surprise if we will not have an interest from anybody at this stage ..

Hopefully someone else has other ideas, other speculations...

My family and friends ( mostly physicians ) , we are excited , since at this stage usually things start to happen , and with these 2 things we know now , cancel distributor and Dr NP statement,
we all checking every morning for PR of BO or big partnership...:))

But only time will tell if we are right.

All IMO.